Please assess the completion status of the following clinical trial:

Trial Title: Dietary Supplementation With Soy Isoflavones in Asthma

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Ages 18-50, males and females~* Physician diagnosis of asthma; requires daily asthma medication~* Moderate persistent disease (NAEPP guidelines)~* FEV1 65 to 90% of predicted~* At least 12% increase in FEV1 15-30 minutes after inhaling 2-4 puffs of albuterol or positive methacholine challenge (20% fall in FEV1 at less than 8 mg/ml) - either of these can available from the previous 2 years~* Generally good health~Exclusion Criteria:~* Oral corticosteroid use within the past 3 months~* Use of high dose inhaled corticosteroids (greater than 500 mcg of fluticasone per day or greater)~* Current or former smoker (quit less than 6 months prior to study enrollment or greater than 10 pack years)~* Recent asthma exacerbation (within 6 weeks)~* Current consumption of soy isoflavone supplements~* Known adverse reaction to genistein, other phytoestrogens, or soy products~* Pregnant~* Unintentional weight loss of more than 10 pounds within the year~* Major or unstable medical condition~* Use of an investigational drug in the previous 30 days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).